These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 22314185)
1. Vascular endothelial growth factor receptor 2 as a marker for malignant vascular tumors and mesothelioma: an immunohistochemical study of 262 vascular endothelial and 1640 nonvascular tumors. Miettinen M; Rikala MS; Rys J; Lasota J; Wang ZF Am J Surg Pathol; 2012 Apr; 36(4):629-39. PubMed ID: 22314185 [TBL] [Abstract][Full Text] [Related]
2. Prox1 transcription factor as a marker for vascular tumors-evaluation of 314 vascular endothelial and 1086 nonvascular tumors. Miettinen M; Wang ZF Am J Surg Pathol; 2012 Mar; 36(3):351-9. PubMed ID: 22067331 [TBL] [Abstract][Full Text] [Related]
3. Keratin 1 expression in endothelia and mesenchymal tumors: an immunohistochemical analysis of normal and neoplastic tissues. Remotti F; Fetsch JF; Miettinen M Hum Pathol; 2001 Aug; 32(8):873-9. PubMed ID: 11521233 [TBL] [Abstract][Full Text] [Related]
4. Claudin-5 as an immunohistochemical marker for angiosarcoma and hemangioendotheliomas. Miettinen M; Sarlomo-Rikala M; Wang ZF Am J Surg Pathol; 2011 Dec; 35(12):1848-56. PubMed ID: 21959309 [TBL] [Abstract][Full Text] [Related]
5. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Partanen TA; Alitalo K; Miettinen M Cancer; 1999 Dec; 86(11):2406-12. PubMed ID: 10590384 [TBL] [Abstract][Full Text] [Related]
6. ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma. Miettinen M; Wang ZF; Paetau A; Tan SH; Dobi A; Srivastava S; Sesterhenn I Am J Surg Pathol; 2011 Mar; 35(3):432-41. PubMed ID: 21317715 [TBL] [Abstract][Full Text] [Related]
7. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Breiteneder-Geleff S; Soleiman A; Kowalski H; Horvat R; Amann G; Kriehuber E; Diem K; Weninger W; Tschachler E; Alitalo K; Kerjaschki D Am J Pathol; 1999 Feb; 154(2):385-94. PubMed ID: 10027397 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Folpe AL; Veikkola T; Valtola R; Weiss SW Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276 [TBL] [Abstract][Full Text] [Related]
9. KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit. Miettinen M; Sarlomo-Rikala M; Lasota J Mod Pathol; 2000 May; 13(5):536-41. PubMed ID: 10824925 [TBL] [Abstract][Full Text] [Related]
10. Distribution of keratins in normal endothelial cells and a spectrum of vascular tumors: implications in tumor diagnosis. Miettinen M; Fetsch JF Hum Pathol; 2000 Sep; 31(9):1062-7. PubMed ID: 11014572 [TBL] [Abstract][Full Text] [Related]
11. Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma. Miettinen M; Limon J; Niezabitowski A; Lasota J Am J Surg Pathol; 2001 May; 25(5):610-7. PubMed ID: 11342772 [TBL] [Abstract][Full Text] [Related]
12. Malignant vascular tumors of the serous membranes mimicking mesothelioma. A report of 14 cases. Lin BT; Colby T; Gown AM; Hammar SP; Mertens RB; Churg A; Battifora H Am J Surg Pathol; 1996 Dec; 20(12):1431-9. PubMed ID: 8944035 [TBL] [Abstract][Full Text] [Related]
13. Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody. Rossi S; Orvieto E; Furlanetto A; Laurino L; Ninfo V; Dei Tos AP Mod Pathol; 2004 May; 17(5):547-52. PubMed ID: 15001993 [TBL] [Abstract][Full Text] [Related]
14. GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Miettinen M; McCue PA; Sarlomo-Rikala M; Rys J; Czapiewski P; Wazny K; Langfort R; Waloszczyk P; Biernat W; Lasota J; Wang Z Am J Surg Pathol; 2014 Jan; 38(1):13-22. PubMed ID: 24145643 [TBL] [Abstract][Full Text] [Related]
15. Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas: An Immunohistochemical Study of 5229 Cases. Miettinen M; Wang Z; Lasota J; Heery C; Schlom J; Palena C Am J Surg Pathol; 2015 Oct; 39(10):1305-12. PubMed ID: 26099010 [TBL] [Abstract][Full Text] [Related]
16. Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics. Folpe AL; Chand EM; Goldblum JR; Weiss SW Am J Surg Pathol; 2001 Aug; 25(8):1061-6. PubMed ID: 11474291 [TBL] [Abstract][Full Text] [Related]
17. B72.3 and CD34 immunoreactivity in malignant epithelioid soft tissue tumors. Adjuncts in the recognition of endothelial neoplasms. Sirgi KE; Wick MR; Swanson PE Am J Surg Pathol; 1993 Feb; 17(2):179-85. PubMed ID: 7678485 [TBL] [Abstract][Full Text] [Related]
18. Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study. Lucas DR; Pass HI; Madan SK; Adsay NV; Wali A; Tabaczka P; Lonardo F Histopathology; 2003 Mar; 42(3):270-9. PubMed ID: 12605647 [TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis. Bonnesen B; Pappot H; Holmstav J; Skov BG Lung Cancer; 2009 Dec; 66(3):314-8. PubMed ID: 19324448 [TBL] [Abstract][Full Text] [Related]
20. Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues. Fanburg-Smith JC; Miettinen M Hum Pathol; 2001 Sep; 32(9):976-83. PubMed ID: 11567228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]